Christopher Joyce

Christopher Joyce, MBA, PharBE, is the Vice President of Business Development at Talus Bio, where he spearheads the company’s strategic partnerships and business development initiatives. With over 15 years of experience in biotechnology and commercialization, he plays a pivotal role in advancing Talus Bio’s platform and growing pipeline toward clinical applications. Before joining Talus Bio, he held key business development roles at Absci, Adaptive Biotechnologies, and Fred Hutchinson Cancer Center, contributing to innovation and growth across the biotech landscape. Mr. Joyce earned both his Master of Business Administration (MBA) and Master of Pharmaceutical Bioengineering (PharBE) from the University of Washington.